Lv2
108 积分 2024-02-28 加入
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
8天前
已完结
Universal Barcoding Predicts In Vivo ApoE-Independent Lipid Nanoparticle Delivery
23天前
已完结
RNA-targeting and gene editing therapies for transthyretin amyloidosis
24天前
已完结
Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses
1个月前
已完结
RNA-targeting and gene editing therapies for transthyretin amyloidosis
1个月前
已完结
Chemical engineering of CRISPR–Cas systems for therapeutic application
4个月前
已完结
Frameworks for transformational breakthroughs in RNA-based medicines
5个月前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
5个月前
已完结
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
6个月前
已完结
皖公网安备34019202002308
